Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral Inflammation and Microbiome Dysbiosis Exacerbate Chronic Graft-versus-host Disease.
Kambara Y, Fujiwara H, Yamamoto A, Gotoh K, Tsuji S, Kunihiro M, Oyama T, Terao T, Sato A, Tanaka T, Peltier D, Seike K, Nishimori H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Soga Y, Reddy P, Maeda Y. Kambara Y, et al. Among authors: nishimori h. Blood. 2024 Dec 18:blood.2024024540. doi: 10.1182/blood.2024024540. Online ahead of print. Blood. 2024. PMID: 39693612
Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
Sugiyama H, Maeda Y, Nishimori H, Yamasuji Y, Matsuoka K, Fujii N, Kondo E, Shinagawa K, Tanaka T, Takeuchi K, Teshima T, Tanimoto M. Sugiyama H, et al. Among authors: nishimori h. Biol Blood Marrow Transplant. 2014 Feb;20(2):183-91. doi: 10.1016/j.bbmt.2013.11.018. Epub 2013 Dec 10. Biol Blood Marrow Transplant. 2014. PMID: 24333142 Free article.
Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
Iwamoto M, Ikegawa S, Kondo T, Meguri Y, Nakamura M, Sando Y, Sugiura H, Sumii Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Shibakura M, Maeda Y, Matsuoka KI. Iwamoto M, et al. Among authors: nishimori h. Bone Marrow Transplant. 2021 Apr;56(4):956-959. doi: 10.1038/s41409-020-01100-0. Epub 2020 Oct 30. Bone Marrow Transplant. 2021. PMID: 33128029 No abstract available.
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML.
Terao T, Matsuoka KI, Ueda H, Matsumura A, Matsubara C, Kondo K, Kondo T, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y. Terao T, et al. Among authors: nishimori h. Blood Adv. 2023 Mar 14;7(5):681-686. doi: 10.1182/bloodadvances.2022008991. Blood Adv. 2023. PMID: 36583677 Free PMC article. No abstract available.
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: nishimori h. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
270 results